Quantitative single-molecule detection analysis method and platform for detecting low-abundance biomarker protein based on proximity ligation

By a method of amplifying nucleic acid signals in a system of tens of thousands of droplets, the low sensitivity and accuracy of existing adjacent linkage techniques have been solved, enabling high-sensitivity and high-accuracy quantitative detection of low-abundance biomarker proteins.

CN119020474APending Publication Date: 2024-11-26WENZHOU INST UNIV OF CHINESE ACAD OF SCI
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410915408.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-09
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing real-time quantitative PCR detection methods based on adjacent linkage technology have low sensitivity and accuracy, making it difficult to meet the requirements for high-resolution and high-sensitivity detection of low-abundance biomarker proteins.

Method used

The reaction system is evenly distributed in tens of thousands of droplets, and the signal is amplified by nucleic acid amplification. Combined with adjacent probes and PCR reaction, multiplex protein detection and quantification are achieved.

Benefits of technology

It improves the signal detection rate of low-concentration proteins in droplets, achieves high-sensitivity and high-precision quantitative detection of low-abundance biomarker proteins, simplifies the operation steps, avoids the washing step, and improves detection sensitivity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020474A_ABST
    Figure CN119020474A_ABST
Patent Text Reader

Abstract

The invention provides a single molecule detection analysis method and platform for detecting low-abundance biomarker protein quantification based on proximity ligation, and solves the technical problems of low sensitivity and low precision of the existing PLA-based real-time fluorescent quantitative PCR detection method. According to the invention, a reaction system is averagely divided into a plurality of micro-droplet systems, QPCR or PCR cyclic amplification reaction is completed in micro-droplets, and signal amplification is realized, so that the concentration of protein, DNA or RNA is accurately quantified. According to the invention, reaction systems are uniformly distributed in a plurality of liquid drop systems, and signal amplification is carried out on the reaction systems by virtue of a nucleic acid amplification technology, so that the signal detection rate of low-concentration protein in liquid drops is improved, and multiple protein detection quantification can be carried out.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biological detection technology, and in particular to a single-molecule detection and analysis method and platform based on proximity ligation for quantitative detection of low-abundance biomarker proteins. Background Art

[0002] Quantification of pathogen and host biomarkers is essential for diagnosis, monitoring, and treatment of disease. Longitudinal biomarker analysis requires rapid sample processing, the ability to detect small differences between samples (i.e., high resolution) and low concentrations of analytes (i.e., low limits of detection), while using as little biological sample as possible. High resolution is required to determine whether different readings at different time points correspond to true biological differences or measurement noise. However, most commercially available molecular detection platforms for cytokine quantification are based on ELISA, which generally have poor sensitivity, are not suitable for simultaneous measurement with other types of biomarkers (e.g., DNA and RNA), and require large amounts of sample.

[0003] Proximity Ligation Assay (PLA) is a highly sensitive in vitro protein analysis technology based on an enzyme-linked mechanism and a linker (an artificially designed linear oligonucleotide single chain, whose two ends can be complementary to a specific target sequence. When the linker hybridizes with the target sequence, they will be close to each other in space, and the two ends of the probe can be connected into a chain under the action of DNA ligase). This method first uses a pair of proximity probes to dual-recognize the target molecule to generate an amplifiable detection signal, and then realizes timed quantitative detection through quantitative PCR, converting the detection of protein into the detection of DNA, with extremely high sensitivity and specificity. PLA can analyze the signal of low-abundance proteins by amplifying antibody-antigen binding events, making it suitable for the development of multiplex detection for simultaneous quantification of protein and nucleic acid targets. However, traditional PLA relies on real-time fluorescence quantitative PCR (qPCR) readings, standards and standard curves formed by curve fitting, and has high measurement noise, low resolution, low accuracy and low sensitivity. Summary of the invention

[0004] The present invention aims to solve the technical problems of low sensitivity and low precision of existing PLA-based real-time fluorescence quantitative PCR detection methods, and to provide a single-molecule detection and analysis method and platform based on proximity ligation for quantitative detection of low-abundance biomarker proteins with high sensitivity and precision.

[0005] The present invention evenly distributes the reaction system in tens of thousands of droplet systems, and performs signal amplification on them through nucleic acid amplification, thereby improving the signal detection rate of low-concentration proteins in the droplets, and can perform multiple protein detection quantification.

[0006] The present invention provides a single molecule detection and analysis method for detecting low-abundance biomarker protein quantification based on proximity ligation, comprising the following steps:

[0007] The first step is to prepare an proximity probe pair, wherein the proximity probe pair consists of proximity probe I and proximity probe II;

[0008] The second step is to dilute the proximity probe I and the proximity probe II respectively with an antibody diluent, and then mix the diluted proximity probe I and the proximity probe II evenly to prepare a proximity probe mixed solution;

[0009] The third step is to take the sample to be tested, add the adjacent probe mixture to the sample to be tested, and incubate to prepare an incubation solution;

[0010] Step 4: prepare the PCR reaction system;

[0011] Step 5, mixing the PCR reaction system with the incubation solution to prepare a PCR premix solution;

[0012] Step 6: Divide the PCR premix into numerous microdroplets;

[0013] Step 7: Perform PCR amplification reaction on the numerous microdroplets;

[0014] Step 8, collecting images of numerous microdroplets after the amplification reaction;

[0015] The ninth step is to process the image and calculate the number of molecules to be measured.

[0016] Preferably, in the first step, the proximity probe I is formed by coupling an antibody I containing a thiol group and an oligonucleotide chain I containing a maleimide group at the 5' end, and the nucleotide sequence of the oligonucleotide chain I is shown in SEQ ID NO.1; the proximity probe II is formed by coupling an antibody II containing a thiol group and an oligonucleotide chain II containing a maleimide group at the 3' end, and the nucleotide sequence of the oligonucleotide chain II is shown in SEQ ID NO.2; antibody I and antibody II are monoclonal antibodies that specifically recognize cytokines, and the two have different antigenic determinants.

[0017] Preferably, in the fourth step, the PCR reaction system includes a linker, T4 DNA Ligase, Forward primer, Reverse primer, Taqman Probe, dNTP, ATP, Buffer, Taq DNA polymerase, BSA, Tween-20, and ddH2O; the linker is shown in SEQ ID NO.3, the Forward primer is shown in SEQ ID NO.4, the Reverse primer is shown in SEQ ID NO.5, the Taqman Probe is shown in SEQ ID NO.6, and the 5' end of the Taqman Probe is labeled with a FAM fluorescent reporter group;

[0018] In the fifth step, the PCR reaction system and the incubation solution are mixed in the well plate, and after mixing, a connection reaction is run in the PCR amplification module to prepare a PCR premix.

[0019] Preferably, in the fourth step, the PCR reaction system includes Forward primer, Reverse primer, Taqman Probe, dNTP, Buffer, Taq DNA polymerase, BSA, Tween-20, and ddH2O; the Forward primer is as shown in SEQ ID NO.7, the Reverse primer is as shown in SEQ ID NO.8, the Taqman Probe is as shown in SEQ ID NO.9, and the 5' end of the Taqman Probe is labeled with a HEX fluorescent reporter group;

[0020] In the fifth step, the PCR reaction system and the incubation solution are mixed in the well plate.

[0021] Preferably, in the fourth step, the PCR reaction system includes Forward primer, Reverse primer, TaqmanProbe, dNTP, Buffer, Taq DNA polymerase, ReverseTranscriptase, BSA, Tween-20, and ddH2O, the Forward primer is as shown in SEQ ID NO.10, the Reverse primer is as shown in SEQ ID NO.11, the TaqmanProbe is as shown in SEQ ID NO.12, and the 5' end of the TaqmanProbe is labeled with a HEX fluorescent reporter group;

[0022] In the fifth step, the PCR reaction system and the incubation solution are mixed in the well plate, and after mixing, a reverse transcription reaction is run in the PCR amplification module to prepare a PCR premix.

[0023] Preferably, the sixth step is to divide the PCR premix into a plurality of microdroplets by a microfluidic chip;

[0024] The microfluidic chip is provided with a sample channel, an oil phase channel, a sample injection port, an oil phase injection port, an outlet, and a collection chamber. The oil phase channel is rectangular as a whole, the sample channel is linear as a whole, the sample channel crosses one side of the oil phase channel, the oil phase injection port is connected to the other side of the oil phase channel through a channel, the sample injection port is connected to one end of the sample channel, the other end of the sample channel is connected to the collection chamber, the outlet is connected to the collection chamber through a channel, and the collection chamber is provided with a micro-dam array;

[0025] The PCR premix is ​​injected from the sample injection port of the microfluidic chip, and the oil phase is injected from the oil phase injection port. The PCR premix is ​​divided into numerous micro droplets and distributed in the collection chamber.

[0026] Preferably, the eighth step is to collect images of the plurality of microdroplets after the amplification reaction by using a laser confocal microscope.

[0027] Preferably, in the ninth step, the micro-droplets in the image are distinguished into positive droplets and negative droplets, and then the number of molecules to be measured is calculated according to the number of positive droplets and negative droplets.

[0028] The present invention also provides a single-molecule detection and analysis platform based on proximity ligation for quantitative detection of low-abundance biomarker proteins, comprising:

[0029] An proximity probe pair preparation device is configured to prepare an proximity probe pair, the proximity probe pair consisting of proximity probe I and proximity probe II;

[0030] The proximity probe mixed solution preparation device is configured to: dilute the proximity probe I and the proximity probe II respectively with the antibody diluent, and then mix the diluted proximity probe I and the proximity probe II evenly to prepare the proximity probe mixed solution;

[0031] The incubation solution preparation device is configured to: take a sample to be detected, add a mixed solution of proximity probes to the sample to be detected, and incubate the sample to obtain an incubation solution;

[0032] The PCR reaction system preparation device is configured to: prepare a PCR reaction system;

[0033] The PCR premix preparation device is configured to: mix the PCR reaction system with the incubation solution to prepare the PCR premix;

[0034] The micro-droplet generating device is configured to: divide the PCR premix solution into a plurality of micro-droplets;

[0035] The PCR amplification device is configured to: perform PCR amplification reaction on a plurality of micro-droplets;

[0036] An image acquisition device is configured to: acquire images of a plurality of micro-droplets after an amplification reaction;

[0037] The data processing device is configured to: perform computational processing on the image to calculate the number of molecules to be measured.

[0038] The effective effect of the present invention is that the present invention evenly divides the reaction reagent into a large number of tiny droplets, performs single-molecule template PCR amplification, and calculates the protein and mRNA copy numbers in the sample according to the number of positive reaction units, without relying on standard curves and standards. Compared with traditional real-time fluorescence quantitative PCR, the interpretation is simpler, and the sensitivity and accuracy are higher. It can directly quantify and measure the protein and mRNA copy numbers, can quantify very small changes in the concentrations of these molecules, and can achieve sub-femtomol resolution of protein targets.

[0039] The reaction system is evenly distributed in tens of thousands of droplet systems, and the signal is amplified through nucleic acid amplification technology, which improves the signal detection rate of low-concentration proteins in the droplets.

[0040] The present invention can perform multiple protein and nucleic acid quantitative detection. The process does not involve a cleaning step, and does not require additional microspheres or other means to increase the hole-falling rate, thereby simplifying the operating steps and improving the detection sensitivity.

[0041] The present invention does not involve a cleaning step, which is beneficial to improving detection sensitivity.

[0042] The present invention enables multiplexed detection of simultaneous quantitative protein and nucleic acid targets. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] Figure 1 is a flow chart for the preparation of proximity probe pairs for detecting cytokine protein concentrations;

[0044] Figure 2 is a flow chart of the detection and analysis method;

[0045] Figure 3 It is a schematic diagram of the structure of the microfluidic chip;

[0046] Figure 4 It is a schematic diagram of the structure of the microfluidic chip placed in the PCR amplification module;

[0047] Figure 5 It is the laser confocal microscopy detection image of different concentrations of cytokine IL-6 protein;

[0048] Figure 6 Yes Figure 5 A graph showing statistical analysis of the number of negative and positive droplets.

[0049] Explanation of symbols in the figure:

[0050] 1. Microfluidic chip, 1-1. Sample channel, 1-2. Oil phase channel, 1-3. Sample injection port, 1-4. Oil phase injection port, 1-5. Outlet, 1-6. Collection chamber; 2. Micro droplets; 3. PCR heating module, 4. Heat dissipation module. DETAILED DESCRIPTION

[0051] The present invention will be further described in detail below with reference to the accompanying drawings by way of specific embodiments.

[0052] The present invention is a single-molecule detection and analysis method and platform for quantitative detection of low-abundance biomarker proteins, which is further developed based on the proximity ligation technology. The reaction system is evenly distributed in tens of thousands of droplet systems, and the signal is amplified by nucleic acid amplification technology, thereby improving the signal detection rate of low-concentration proteins in the droplets, and can simultaneously quantify multiple detections of protein and nucleic acid targets.

[0053] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be understood as limiting the scope of protection of the present invention. The reagents or raw materials used in the following examples are commercially available unless otherwise specified. The antibodies used in the examples were purchased from Suzhou Jinan Protein Technology Co., Ltd., wherein antibody I is Human IL-6antibody (15H5) and antibody II is Human IL-6antibody (19D6). Antibody I and antibody II are monoclonal antibodies that specifically recognize the cytokine, and the two have different antigenic determinants; the cytokine is the cytokine IL-6.

[0054] The first step, reference Figure 1 , prepare a proximity probe pair for detecting cytokine protein concentration, the proximity probe pair consisting of proximity probe I and proximity probe II.

[0055] Step 1, prepare proximity probe I.

[0056] Step (1), activation of NH2-modified oligonucleotide chain I:

[0057] 1) Take 3 μL of 100 μM amino-modified oligonucleotide chain I, add 4.5 μL of 4 mM sulfo-SMCC cross-linking agent, incubate at room temperature for 1 hour and then stand to prepare mixed solution I; oligonucleotide chain I is shown in SEQ ID NO.1;

[0058] 2) Add 20 μL 5M NaCl and 1 mL 100% ice ethanol (-20°C) to the mixed solution I, mix well, and let stand at -20°C for 30-60 min to obtain a mixed solution II;

[0059] 3) Centrifuge the mixed solution II at 13200 rpm for 8 min, discard the supernatant to remove excess sulfo-SMCC cross-linking agent, take the precipitate, add 1 mL of 70% ice ethanol, rinse the residual salt and dry it to obtain the oligonucleotide chain I containing maleimide group (MCC-Oligo-I);

[0060] 4) The MCC-Oligo-I prepared in step 3) was dissolved by adding 20 μL of PBS containing 20 mM EDTA to obtain a solution of oligonucleotide chain I (MCC-Oligo-I) containing a maleimide group for later use.

[0061] Step (2), introducing thiol groups into antibodies:

[0062] 1) Pass the commercially available antibody I through a 50KDa ultrafiltration column to remove the sodium azide in the antibody protection solution to prevent the sodium azide from affecting subsequent reactions;

[0063] 2) taking 50 μg of antibody I treated in step 1), adding 20 μL of 0.5 mM 2-iminothiolane hydrochloride (2-IT), and incubating at room temperature for 1 hour; after 1 hour, passing through a 50 KDa ultrafiltration column to obtain the desalted antibody I to be coupled with the thiol group introduced;

[0064] Step (3), take 20 μg of the antibody I to be coupled obtained in step (2), add 3 μL of the oligonucleotide chain I solution containing maleimide groups obtained in step (1), incubate at room temperature for 1 hour, then add 10 μL of 10 mM N-acetylmaleimide (NEM) aqueous solution to block the remaining thiol groups on the antibody, leave at room temperature for 2 hours, and then pass through a YM-50 centrifugal filter column (YM-50 centrifugal filter column is a product of Millipore) to remove uncoupled Oligo DNA to obtain the final proximity probe I. It can be seen that the proximity probe I is formed by coupling the antibody I containing a thiol group and the oligonucleotide chain I containing a maleimide group at the 5' end.

[0065] Step 2, prepare proximity probe II.

[0066] Step (1), activation of NH2-modified oligonucleotide chain II:

[0067] 1) Take 3 μL of 100 μM amino-modified oligonucleotide chain II, add 4.5 μL of 4 mM sulfo-SMCC cross-linking agent, incubate at room temperature for 1 hour and then let stand to prepare mixed solution I; oligonucleotide chain II is shown in SEQ ID NO.2.

[0068] 2) Add 20 μL 5M NaCl and 1 mL 100% ice ethanol (-20°C) to the mixed solution I, mix well, and let stand at -20°C for 30-60 min to obtain a mixed solution II;

[0069] 3) Centrifuge the mixed solution II at 13200 rpm for 8 min, discard the supernatant to remove excess sulfo-SMCC cross-linking agent, take the precipitate, add 1 mL of 70% ice ethanol, rinse the residual salt and dry it to obtain the oligonucleotide chain II containing maleimide group (MCC-Oligo-I);

[0070] 4) The MCC-Oligo-I prepared in step 3) was added to 20 μL of PBS containing 20 mM EDTA to dissolve, and a solution of oligonucleotide chain II (MCC-Oligo-I) containing maleimide groups was obtained for later use.

[0071] Step (2), introducing thiol groups into antibodies:

[0072] 1) Pass the commercially available antibody II through a 50KDa ultrafiltration column to remove sodium azide in the antibody protection solution to prevent sodium azide from affecting subsequent reactions;

[0073] 2) taking 50 μg of antibody II treated in step 1), adding 20 μL of 0.5 mM 2-iminothiolane hydrochloride (2-IT), and incubating at room temperature for 1 hour; after 1 hour, passing through a 50 KDa ultrafiltration column to obtain the desalted antibody II to be coupled with the thiol group introduced;

[0074] Step (3), take 20 μg of the antibody II to be coupled obtained in step (2), add 3 μL of the oligonucleotide chain II solution containing maleimide group obtained in step (1), incubate at room temperature for 1 hour, then add 10 μL of 10 mM N-acetylmaleimide (NEM) aqueous solution to block the remaining thiol groups on the antibody, leave at room temperature for 2 hours, and then pass through a YM-50 centrifugal filter column to remove the uncoupled Oligo DNA to obtain the final proximity probe II. It can be seen that the proximity probe II is formed by coupling the antibody II containing thiol group and the oligonucleotide chain II containing maleimide group at the 3' end.

[0075] In the second step, the proximity probe I and proximity probe II are diluted to 1 μg / mL respectively with an antibody diluent (PBS solution containing 0.05% (v / v) Tween-20), and then the diluted proximity probe I and proximity probe II are mixed evenly to prepare a proximity probe mixed solution. The concentration of proximity probe I in the proximity probe mixed solution is 500 ng / mL, and the concentration of proximity probe II in the proximity probe mixed solution is 500 ng / mL.

[0076] The third step is to take 50 μL of the sample to be tested, add 50 μL of the adjacent probe mixture to the sample to be tested, oscillate and mix well, centrifuge for 3-5 seconds, and incubate at room temperature for 1 hour to obtain an incubation solution.

[0077] The fourth step is to prepare the PCR reaction system.

[0078] Different PCR reaction systems are configured for different detection purposes.

[0079] In the first case, when detecting proteins in samples, the configured PCR reaction system is shown in Table 2 below:

[0080] Table 2:

[0081] Components Volume (μL) Linker (10μM) 2.0 T4 DNA Ligase (600U / μL) 2.0 Forward primer (10 μM) 3.5 Reverse primer (10 μM) 3.5 Taqman Probe (10 μM) 1.5 dNTP(20mM) 0.5 ATP(10mM) 2.0 Buffer 15.0 Taq DNA polymerase (5U / μL) 0.5 20mg / mL BSA 1.0 10% Tween-20 1.0 <![CDATA[ddH2O]]> 12.5 total 45.0

[0082] The linker in the PCR reaction system is shown as SEQ ID NO.3, the forward primer is shown as SEQ ID NO.4, the reverse primer is shown as SEQ ID NO.5, the Taqman probe is shown as SEQ ID NO.6, and the 5' end of the Taqman probe is labeled with a FAM fluorescent reporter group.

[0083] In the second case, when detecting DNA in a sample, the configured PCR reaction system is shown in Table 4 below:

[0084] Table 4:

[0085] Components Volume (μL) Forward primer (10μM) 3.5 Reverse primer (10 μM) 3.5 Taqman Probe (10 μM) 1.5 dNTP(20mM) 0.5 Buffer 15.0 Taq DNA polymerase (5U / μL) 0.5 20mg / mL BSA 1.0 10% Tween-20 1.0 <![CDATA[ddH2O]]> 18.5 total 45.0

[0086] The forward primer in the PCR reaction system is shown as SEQ ID NO.7, the reverse primer is shown as SEQ ID NO.8, the Taqman probe is shown as SEQ ID NO.9, and the 5' end of the Taqman probe is labeled with a HEX fluorescent reporter group.

[0087] In the third case, when detecting RNA in a sample, the configured PCR reaction system is shown in Table 5 below:

[0088] Table 5:

[0089] Components Volume (μL) Forward primer (10μM) 3.5 Reverse primer (10 μM) 3.5 Taqman Probe (10 μM) 1.5 dNTP(20mM) 0.5 Buffer 15.5 Taq DNA polymerase (5U / μL) 0.75 MMLV ReverseTranscriptase 0.4 20mg / mL BSA 1.0 10% Tween-20 1.0 <![CDATA[ddH2O]]> 17.35 total 45.0

[0090] The forward primer in the PCR reaction system is shown as SEQ ID NO.10, the reverse primer is shown as SEQ ID NO.11, and the Taqman probe is shown as SEQ ID NO.12. The 5' end of the Taqman probe is labeled with a HEX fluorescent reporter group.

[0091] Step 5: Prepare PCR premix.

[0092] There are three situations. For the first situation when detecting protein in the sample, the total amount of PCR Mix required is calculated according to the number of reaction wells in the well plate (PCR Mix refers to the volume of the PCR reaction system obtained in the fourth step multiplied by the number of wells), and the PCR Mix is ​​evenly divided into 96-well plates (45μL per well), and then 5μL of incubation solution is added. After mixing, the ligation reaction is run in the PCR amplification module of the digital PLA detector to prepare the PCR premix. During the ligation reaction, the temperature of the ligation process is 37°C and the duration is 30min, and the temperature of the inactivation process is 65°C and the duration is 10min.

[0093] For the second case when detecting DNA in the sample, the total amount of PCR Mix required was calculated according to the number of reaction wells of the well plate, and the PCR Mix was evenly divided into 96-well plates (45 μL per well), and 5 μL of incubation solution was added to prepare a PCR premix.

[0094] For the third case when detecting RNA in the sample, the total amount of PCR Mix required is calculated according to the number of reaction wells in the well plate, and the PCR Mix is ​​evenly divided into 96-well plates (45 μL per well), and 5 μL of incubation solution is added. After mixing, the reverse transcription reaction is run in the PCR amplification module of the digital PLA detector to prepare the PCR premix. During the reverse transcription reaction, the temperature of the reverse transcription is 37°C and the duration is 30 minutes, and the temperature of the inactivation process is 70°C and the duration is 10 minutes.

[0095] Step 6: Generate microdroplets.

[0096] like Figure 3 As shown, the microfluidic chip 1 is provided with a sample channel 1-1, an oil phase channel 1-2, a sample injection port 1-3, an oil phase injection port 1-4, an outlet 1-5, and a collection chamber 1-6. The oil phase channel 1-2 is rectangular as a whole, the sample channel 1-1 is linear as a whole, the sample channel 1-1 crosses one side of the oil phase channel 1-2, the oil phase injection port 1-4 is connected to the other side of the oil phase channel 1-2 through a channel, the sample injection port 1-3 is connected to one end of the sample channel 1-1, the other end of the sample channel 1-1 is connected to the collection chamber 1-6, and the outlet 1-5 is connected to the collection chamber 1-6 through a channel. The collection chamber 1-6 is provided with a micro-dam array.

[0097] Prepare two micro-syringe pumps, one of which contains the PCR master mix and the other contains the oil phase.

[0098] One micro-injection pump works to inject the PCR premix from the sample injection port 1-3 of the microfluidic chip, and another micro-injection pump works to inject the oil phase from the oil phase injection port 1-4. The oil phase flows in the oil phase channel 1-2, and the PCR premix flows in the sample channel 1-1. At the cross structure, Figure 3 As shown, the PCR premix in the sample channel 1-1 is cut into nanoliter droplets (about 50 um in diameter) by the shear force of the flowing fluid under the action of the oil phases on both sides, and the independent droplets are continuously transported to the collection chamber 1-6, so that tens of thousands of emulsion droplets can be formed within a certain period of time.

[0099] Since the size between the micro-dams in the collection chamber 1-6 is less than 25um (i.e., smaller than the radius of the micro-droplet), the micro-droplet is intercepted at the micro-dam, and the micro-droplet 2 remains at the micro-dam. All the micro-droplets are gathered and concentrated in the collection chamber 1-6, and the oil phase flows through the collection chamber 1-6 and is discharged from the outlet 1-5.

[0100] Then, the sample inlet 1-3, the oil phase inlet 1-4 and the outlet 1-5 were sealed with a cover plate made of PDMS.

[0101] The oil phase can specifically be fluorocarbon oil HFE7500, FC40, silicone oil PMX-200, 5225C; mineral oil n-tetradecane, n-dodecane, diethylhexyl carbonate, etc.

[0102] It should be noted that dividing the PCR premix into tens of thousands of microdroplets by using a microfluidic chip is only a specific implementation method. The PCR premix can also be divided into tens of thousands of microdroplets and carried by other methods.

[0103] In the seventh step, the microfluidic chip with tens of thousands of microdroplets is transferred to the PCR amplification module in the digital PLA detector for PCR amplification reaction.

[0104] The conditions of the PCR amplification reaction are shown in Table 7 below. The amplification enzyme was thermally activated at 95°C for 10 min. After thermal activation, 35 PCR cycles were performed.

[0105] Table 7

[0106]

[0107] After the PCR amplification reaction is completed, the microfluidic chip is taken out from the PCR amplification module.

[0108] The QPCR or PCR cycle amplification reaction is completed inside the microdroplet to achieve signal amplification, which is conducive to the accurate quantification of protein concentration or other molecular concentrations.

[0109] Step 8. Prepare a laser confocal microscope, turn on the laser confocal microscope, set the excitation light wavelength, and select the corresponding filter.

[0110] Place the microfluidic chip under a laser confocal microscope.

[0111] In visual mode, adjust the magnification of the objective lens used and find the microdroplets to be detected under the microscope. Switch to scanning mode and adjust the scanning parameters. Select the appropriate image resolution, scan the area where the microdroplets to be detected are located, and save the image.

[0112] The ninth step is to process the image computationally, and the data processing unit calculates the number of protein molecules, DNA molecules, or RNA molecules. For example, the data processing unit counts the number of positive droplets and negative droplets, and then calculates the number of protein molecules, DNA molecules, or RNA molecules based on the number of positive droplets and negative droplets (for example, using the statistical principle of Poisson distribution to calculate the number of molecules), thereby achieving detection at the single molecule level. Positive droplets and negative droplets can be determined based on the type of fluorescent signal and its intensity; for example, if the fluorescent signal is green, the positive droplets appear bright green, while the negative droplets appear relatively dark.

[0113] When the test sample contains protein, the number of protein molecules is calculated. When the test sample contains DNA, the number of DNA molecules is calculated. When the test sample contains RNA, the number of RNA molecules is calculated.

[0114] Regarding protein detection, a group of different concentrations of cytokine IL-6 protein were prepared, and the concentrations were 20.0pg / mL, 2.0pg / mL, 0.20pg / mL, and 0.02pg / mL. According to the above operation process, we tested the protein content in the samples. The results are as follows Figure 5 and 6 It can be seen that the present invention can detect protein content as low as 0.02pg / mL. Figure 6 In OriginLab data analysis software, nonlinear curve fitting is performed between signal value and concentration. The fitting equation is

[0115] y=A2+(A1-A2) / (1+(x / x0)^p), where A1 is 302.05444±105.70969, A2 is 10536.11394±1280.66581, x0 is 4.63512±1.61857, p is 1.02129±0.21446, and the Reduced Chi-Sqr of the obtained equation is 18095.1227, R square (COD) is 0.99965, and the adjusted R square is 0.99859.

[0116] It should be noted that dividing the PCR premix into tens of thousands of microdroplets is only an example and does not limit the scope of patent protection. The PCR premix can also be divided into thousands of microdroplets, or even hundreds of thousands of microdroplets. The specific number of microdroplets can be matched with a laser confocal microscope for scanning and image acquisition.

[0117] Although the present invention has been disclosed as above in the preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.

[0118] The sequences in Table 8 are, in order, oligonucleotide chain I, oligonucleotide chain II, linker required for detecting protein concentration, Forward Primer required for detecting protein concentration, Reverse primer required for detecting protein concentration, Taqman probe required for detecting protein concentration, Forward primer required for detecting DNA concentration, Reverse primer required for detecting DNA concentration, Taqman probe required for detecting DNA concentration, Forward primer required for detecting RNA concentration, Reverse primer required for detecting RNA concentration, and Taqman probe required for detecting RNA concentration.

[0119] Table 8 Sequence

[0120]

Claims

1. A single-molecule detection and analysis method based on proximity ligation for the quantitative detection of low-abundance biomarker proteins. Its characteristics are: The following steps are involved: The first step is to prepare an proximity probe pair, wherein the proximity probe pair consists of proximity probe I and proximity probe II; The second step is to dilute the proximity probe I and the proximity probe II respectively with an antibody diluent, and then mix the diluted proximity probe I and the proximity probe II evenly to prepare a proximity probe mixed solution; The third step is to take the sample to be tested, add the adjacent probe mixture to the sample to be tested, and incubate to prepare an incubation solution; Step 4: prepare the PCR reaction system; Step 5, mixing the PCR reaction system with the incubation solution to prepare a PCR premix solution; Step 6: Divide the PCR premix into numerous microdroplets; Step 7: Perform PCR amplification reaction on the numerous microdroplets; Step 8, collecting images of numerous microdroplets after the amplification reaction; The ninth step is to process the image and calculate the number of molecules to be measured.

2. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 1, Features: In the first step, the proximity probe I is formed by coupling an antibody I containing a thiol group and an oligonucleotide chain I containing a maleimide group at the 5' end, and the nucleotide sequence of the oligonucleotide chain I is shown in SEQ ID NO.1; the proximity probe II is formed by coupling an antibody II containing a thiol group and an oligonucleotide chain II containing a maleimide group at the 3' end, and the nucleotide sequence of the oligonucleotide chain II is shown in SEQ ID NO.2; the antibody I and the antibody II are monoclonal antibodies that specifically recognize cytokines, and the two have different antigenic determinants.

3. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 2, Features: In the fourth step, the PCR reaction system includes a linker, T4 DNA Ligase, forward primer, reverse primer, Taqman Probe, dNTP, ATP, buffer, Taq DNA polymerase, BSA, Tween-20, ddH 2 O; the linker is shown in SEQ ID NO.3, the forward primer is shown in SEQ ID NO.4, the reverse primer is shown in SEQ ID NO.5, the Taqman Probe is shown in SEQ ID NO.6, and the 5' end of the Taqman Probe is labeled with a FAM fluorescent reporter group; In the fifth step, the PCR reaction system and the incubation solution are mixed in the well plate, and after mixing, a connection reaction is run in the PCR amplification module to prepare a PCR premix.

4. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 2, Features: In the fourth step, the PCR reaction system includes forward primer, reverse primer, Taqman Probe, dNTP, buffer, Taq DNA polymerase, BSA, Tween-20, ddH 2 O; the Forward primer is shown as SEQ ID NO.7, the Reverse primer is shown as SEQ ID NO.8, the Taqman Probe is shown as SEQ ID NO.9, and the 5' end of the Taqman Probe is labeled with a HEX fluorescent reporter group; In the fifth step, the PCR reaction system and the incubation solution are mixed in the well plate.

5. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 2, Features: In the fourth step, the PCR reaction system includes forward primer, reverse primer, Taqman Probe, dNTP, buffer, Taq DNA polymerase, reverse transcriptase, BSA, Tween-20, ddH 2 O, the Forward primer is as shown in SEQ ID NO.10, the Reverse primer is as shown in SEQ ID NO.11, the Taqman Probe is as shown in SEQ ID NO.12, and the 5' end of the Taqman Probe is labeled with a HEX fluorescent reporter group; In the fifth step, the PCR reaction system and the incubation solution are mixed in the well plate, and after mixing, a reverse transcription reaction is run in the PCR amplification module to prepare a PCR premix solution.

6. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 1, It is characterized in that The sixth step is to divide the PCR premix into a plurality of micro droplets by using a microfluidic chip; The microfluidic chip is provided with a sample channel, an oil phase channel, a sample injection port, an oil phase injection port, an outlet, and a collection chamber. The oil phase channel is rectangular as a whole, the sample channel is linear as a whole, the sample channel crosses one side of the oil phase channel, the oil phase injection port is connected to the other side of the oil phase channel through a channel, the sample injection port is connected to one end of the sample channel, the other end of the sample channel is connected to the collection chamber, the outlet is connected to the collection chamber through a channel, and the collection chamber is provided with a micro-dam array; The PCR premix is ​​injected from the sample injection port of the microfluidic chip, and the oil phase is injected from the oil phase injection port. The PCR premix is ​​divided into a plurality of micro droplets and distributed in the collection chamber.

7. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 1, It is characterized in that The eighth step is to collect images of numerous microdroplets after the amplification reaction using a laser confocal microscope.

8. The single-molecule detection and analysis method for detecting low-abundance biomarker proteins based on proximity ligation according to claim 7, It is characterized in that In the ninth step, the micro-droplets in the image are distinguished into positive droplets and negative droplets, and then the number of molecules to be measured is calculated according to the number of positive droplets and negative droplets.

9. A single-molecule detection and analysis platform based on proximity ligation for the quantitative detection of low-abundance biomarker proteins. It is characterized in that include: An proximity probe pair preparation device is configured to prepare an proximity probe pair, the proximity probe pair consisting of proximity probe I and proximity probe II; The proximity probe mixed solution preparation device is configured to: dilute the proximity probe I and the proximity probe II respectively with the antibody diluent, and then mix the diluted proximity probe I and the proximity probe II evenly to prepare the proximity probe mixed solution; The incubation solution preparation device is configured to: take a sample to be detected, add a mixed solution of proximity probes to the sample to be detected, and incubate the sample to obtain an incubation solution; The PCR reaction system preparation device is configured to: prepare a PCR reaction system; The PCR premix preparation device is configured to: mix the PCR reaction system with the incubation solution to prepare the PCR premix; The micro-droplet generating device is configured to: divide the PCR premix solution into a plurality of micro-droplets; The PCR amplification device is configured to: perform PCR amplification reaction on a plurality of micro-droplets; An image acquisition device is configured to: acquire images of a plurality of micro-droplets after an amplification reaction; The data processing device is configured to: perform computational processing on the image to calculate the number of molecules to be measured.

Citation Information

Cited By

  • Multi-target simultaneous detection method based on proximity ligation

    CN120102908A